Table 2. Treatments, major complications, and outcomes (N = 12).^a .

Variable	Result
WLL
Number of patients undergoing WLL (n, %)	8 (66.7)
Number of procedures per patient	2.8 ± 2.5
Other forms of treatment
GM-CSF replacement therapy	2 (16.6)
Anti-CD20 monoclonal antibody (rituximab)	2 (16.6)
Neoplasm	1 (8.3)
Infection	4 (33.3)
Tuberculosis	1 (8.3)
Nocardiosis	1 (8.3)
Cryptococcosis	2 (16.6)
Death	2 (16.6)
Neoplasm	1 (8.3)
WLL complications	1 (8.3)

WLL: whole-lung lavage. ^aValues expressed as n (%) or mean ± SD.